Commercialising Academic Innovation: The Celdara Medical Model as a Case Study
Baldwin Spencer theatre - 117
Baldwin Spencer Theatre
T: (03) 8344 9063
See more events from
Celdara Medical is a therapeutic and diagnostic development company, focused on bringing the best innovations and discoveries out of leading academic labs and into human trials. It is currently developing a suite of therapeutic products spanning oncology, inflammation, rare disease, and infectious disease. Hundreds of assets per year are evaluated, yielding a robust and diverse early stage pipeline. Celdara Medical operates a CLIA-certified diagnostic lab for subtyping of patients with scleroderma, both for patients and their caregivers, and for drug developers. It currently has 20 employees and generally ~40 individuals engaged via contract or consulting agreements. There are affiliates in Seattle (Virtici LLC) and Wisconsin (TRV) plus an office in New York. Celdara Medical works with researchers at >20 leading research institutions across the country and some internationally. They have partnered a CAR-T cell therapy program (OnCyte) and are continuing to partner with biotech and pharma partners looking to fill their pipelines with high impact, and rigorously vetted assets and innovations.
Dr Brandy Houser received her PhD in immunology from Harvard University under the guidance of Dr Jack Strominger for the discovery of specialised macrophage subsets at the human maternal-fetal interface.